DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
HALOFUGINONE HYDROBROMIDE
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Sarcoma, Kaposi
Unknown
HALOFUGINONE HYDROBROMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
PTC2969MV1
Molecule Type:
Small molecule
Molecular Formula:
C16H18Br2ClN3O3
Molecular Weight:
495.6
AlogP:
1.88
PSA:
84.22
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NM-404 I-131
2
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms; Glioma
Unknown
NM-404 I-131
×
Maximum Phase:
2
First Approval:
None
UNII:
R048696O9L
Molecule Type:
Small molecule
Molecular Formula:
C29H53INO4P
Molecular Weight:
641.63
AlogP:
8.28
PSA:
58.59
HBD:
0.0
HBA:
#RotB:
24.0
Source:
BZL101
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BZL101
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GM-CT-01
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GM-CT-01
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD1981
2
Small molecule
Investigational
Unknown
Unknown
Infertility; Asthma; Pulmonary Disease, Chronic Obstructive; Urticaria
G protein-coupled receptor 44 antagonist
AZD1981
×
Maximum Phase:
2
First Approval:
None
UNII:
2AD53WQ2CX
Molecule Type:
Small molecule
Molecular Formula:
C19H17ClN2O3S
Molecular Weight:
388.88
AlogP:
4.8
PSA:
71.33
HBD:
2.0
HBA:
#RotB:
5.0
Source:
OLUMACOSTAT GLASARETIL
2
Small molecule
Investigational
Unknown
Unknown
Acne Vulgaris
Acetyl-CoA carboxylase inhibitor
OLUMACOSTAT GLASARETIL
×
Maximum Phase:
2
First Approval:
None
UNII:
4W6JDK2PLY
Molecule Type:
Small molecule
Molecular Formula:
C26H43NO7
Molecular Weight:
481.63
AlogP:
5.54
PSA:
95.28
HBD:
0.0
HBA:
#RotB:
20.0
Source:
2,4-DINITROPHENOL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
2,4-DINITROPHENOL
×
Maximum Phase:
2
First Approval:
None
UNII:
Q13SKS21MN
Molecule Type:
Small molecule
Molecular Formula:
C6H4N2O5
Molecular Weight:
184.11
AlogP:
1.21
PSA:
106.51
HBD:
1.0
HBA:
#RotB:
2.0
Source:
NECATOR AMERICANUS
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NECATOR AMERICANUS
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MILATAXEL
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Mesothelioma; Rectal Neoplasms
Unknown
MILATAXEL
×
Maximum Phase:
2
First Approval:
None
UNII:
J41Q4S20GS
Molecule Type:
Small molecule
Molecular Formula:
C45H56O16
Molecular Weight:
852.93
AlogP:
4.06
PSA:
231.63
HBD:
3.0
HBA:
#RotB:
11.0
Source:
DROZITUMAB
2
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Chondrosarcoma; Lymphoma, Non-Hodgkin
Tumor necrosis factor receptor superfamily member 10B agonist
DROZITUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
SQ67484MA7
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OSI-7904
2
Small molecule
Investigational
Unknown
Unknown
Colorectal Neoplasms; Neoplasms; Head and Neck Neoplasms
Thymidylate synthase inhibitor
OSI-7904
×
Maximum Phase:
2
First Approval:
None
UNII:
ON177ZCE7M
Molecule Type:
Small molecule
Molecular Formula:
C27H24N4O6
Molecular Weight:
500.51
AlogP:
3.27
PSA:
152.69
HBD:
4.0
HBA:
#RotB:
8.0
Source:
PISTACHIO
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PISTACHIO
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RESEQUINIL
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
GABA-A receptor; anion channel inverse agonist
RESEQUINIL
×
Maximum Phase:
2
First Approval:
None
UNII:
2G222T03EY
Molecule Type:
Small molecule
Molecular Formula:
C18H14N4O3
Molecular Weight:
334.34
AlogP:
2.96
PSA:
93.9
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CARBAPENEM
2
Small molecule
Investigational
Unknown
Unknown
Infections
Unknown
CARBAPENEM
×
Maximum Phase:
2
First Approval:
None
UNII:
GL970841YS
Molecule Type:
Small molecule
Molecular Formula:
C7H7NO3
Molecular Weight:
153.14
AlogP:
-0.04
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ONC201
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ONC201
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ONO-5334
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ONO-5334
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHYL PYRUVATE
2
Small molecule
Investigational
Unknown
Unknown
Coronary Disease
Unknown
ETHYL PYRUVATE
×
Maximum Phase:
2
First Approval:
None
UNII:
03O98E01OB
Molecule Type:
Small molecule
Molecular Formula:
C5H8O3
Molecular Weight:
116.12
AlogP:
0.14
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
2.0
Source:
TASIDOTIN HYDROCHLORIDE
2
Protein
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Melanoma; Prostatic Neoplasms, Castration-Resistant
Unknown
TASIDOTIN HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
3382C833Z5
Molecule Type:
Protein
Molecular Formula:
C32H59ClN6O5
Molecular Weight:
643.31
AlogP:
2.09
PSA:
122.37
HBD:
2.0
HBA:
#RotB:
11.0
Source:
ANCESTIM
2
Protein
Investigational
Unknown
Unknown
Myelodysplastic Syndromes; Anemia, Aplastic; Lymphoma; Multiple Myeloma
Unknown
ANCESTIM
×
Maximum Phase:
2
First Approval:
None
UNII:
PYB4Q6JG41
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INT131
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Multiple Sclerosis, Relapsing-Remitting
Peroxisome proliferator-activated receptor gamma modulator
INT131
×
Maximum Phase:
2
First Approval:
None
UNII:
E7ILQ6U50J
Molecule Type:
Small molecule
Molecular Formula:
C21H12Cl4N2O3S
Molecular Weight:
514.22
AlogP:
7.44
PSA:
68.29
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FLAXSEED
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FLAXSEED
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEVIRIMAT
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
BEVIRIMAT
×
Maximum Phase:
2
First Approval:
None
UNII:
S125DW66N8
Molecule Type:
Small molecule
Molecular Formula:
C36H56O6
Molecular Weight:
584.84
AlogP:
8.14
PSA:
100.9
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SB-649868
2
Small molecule
Investigational
Unknown
Unknown
Sleep Wake Disorders; Sleep Initiation and Maintenance Disorders
Orexin receptor 1 antagonist
SB-649868
×
Maximum Phase:
2
First Approval:
None
UNII:
1L1V1K2M4V
Molecule Type:
Small molecule
Molecular Formula:
C26H24FN3O3S
Molecular Weight:
477.56
AlogP:
5.43
PSA:
75.44
HBD:
1.0
HBA:
#RotB:
5.0
Source:
EXBIVIRUMAB
2
Antibody
Investigational
Unknown
Unknown
Hepatitis B, Chronic
Unknown
EXBIVIRUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
5Q374M1S1P
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ONFEKAFUSP ALFA
2
Protein
Investigational
Unknown
Unknown
Glioblastoma; Glioma; Sarcoma
Unknown
ONFEKAFUSP ALFA
×
Maximum Phase:
2
First Approval:
None
UNII:
6HXC0O6JMV
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-0812
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Multiple Sclerosis, Relapsing-Remitting
C-C chemokine receptor type 2 antagonist
MK-0812
×
Maximum Phase:
2
First Approval:
None
UNII:
P3LKY4ZL5O
Molecule Type:
Small molecule
Molecular Formula:
C24H36F3N3O2
Molecular Weight:
455.57
AlogP:
4.05
PSA:
46.62
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CAT-203
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
CAT-203
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RECIFERCEPT
2
Protein
Investigational
Unknown
Unknown
Achondroplasia
Unknown
RECIFERCEPT
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PM-00104
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Endometrial Neoplasms; Uterine Cervical Neoplasms
Unknown
PM-00104
×
Maximum Phase:
2
First Approval:
None
UNII:
C21EZR41AY
Molecule Type:
Small molecule
Molecular Formula:
C37H38F3N3O8
Molecular Weight:
709.72
AlogP:
4.72
PSA:
130.03
HBD:
3.0
HBA:
#RotB:
6.0
Source:
FLUMATINIB
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Tyrosine-protein kinase ABL inhibitor
FLUMATINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
R4009Y24AI
Molecule Type:
Small molecule
Molecular Formula:
C29H29F3N8O
Molecular Weight:
562.6
AlogP:
5.0
PSA:
99.17
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CACP29
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
CACP29
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RIPASUDIL HYDROCHLORIDE DIHYDRATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Rho-associated protein kinase inhibitor
RIPASUDIL HYDROCHLORIDE DIHYDRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
016TTR32QF
Molecule Type:
Small molecule
Molecular Formula:
C15H23ClFN3O4S
Molecular Weight:
395.88
AlogP:
1.75
PSA:
62.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
GLPG0778
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GLPG0778
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-7622
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Muscarinic acetylcholine receptor M1 positive allosteric modulator
MK-7622
×
Maximum Phase:
2
First Approval:
None
UNII:
57R7D1Q49R
Molecule Type:
Small molecule
Molecular Formula:
C25H25N3O2
Molecular Weight:
399.49
AlogP:
4.32
PSA:
68.01
HBD:
1.0
HBA:
#RotB:
3.0
Source:
LABETUZUMAB GOVITECAN
2
Antibody
Investigational
Unknown
Unknown
Colonic Neoplasms; Rectal Neoplasms
Carcinoembryonic antigen-related cell adhesion molecule 5 binding agent
LABETUZUMAB GOVITECAN
×
Maximum Phase:
2
First Approval:
None
UNII:
8E3HI6QQ9J
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
166
167
168
169
170
171
172
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA